Positive results of treatment of adenocystic carcinoma of the parotid salivary gland with lenvatinib

I. A. Filippov; Филиппов И. А.; M. S. Shvedsky; Шведский М. С.; E. A. Gaisina; Гайсина Е. А.; L. A. Bakhova; Бахова Л. А.

doi:10.17650/2222-1468-2024-14-3-10-13

Positive results of treatment of adenocystic carcinoma of the parotid salivary gland with lenvatinib

Authors: Filippov I.A.¹, Shvedsky M.S.², Gaisina E.A.¹^,2, Bakhova L.A.¹^,2
Affiliations:
1. Multidisciplinary Medical Clinical Center “Medical City”
2. Tyumen State Medical University, Ministry of Health of Russia
Issue: Vol 14, No 3 (2024)
Pages: 10-13
Section: DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
Published: 11.11.2024
URL: https://ogsh.abvpress.ru/jour/article/view/999
DOI: https://doi.org/10.17650/2222-1468-2024-14-3-10-13
ID: 999

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

Malignant tumors of the salivary glands account for 3–5 % of all head and neck cancers. Adenocystic carcinomas are malignant neoplasms that most often arise from large and small salivary glands. The disease is characterized by a progressive course with local and distant relapses.
The article presents a clinical case of successful treatment with lenvatinib in suboptimal doses of adenocystic carcinoma of the parotid salivary gland.